Valuation Sanofi Borsa Italiana

Stocks

End-of-day quote Borsa Italiana Other stock markets 2026-07-31			5-day change	1st Jan Change
74.16 ^EUR	+1.87%		-6.82%	-10.69%

08-04	European Stocks Close Higher Tuesday on Earnings Strength, Hormuz Talks	MT
08-04	Nurix Therapeutics Gets $10 Million Milestone Payment as Sanofi Initiates Phase 1 Trial of STAT6 Degrader	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	111,194	112,665	112,549	116,968	100,655	89,124	-	-
Change	-	1.32%	-0.1%	3.93%	-13.95%	-11.46%	-	-
Enterprise Value (EV) ¹	121,177	119,102	120,342	125,740	111,663	100,492	96,800	93,333
Change	-	-1.71%	1.04%	4.49%	-11.2%	-10%	-3.67%	-3.58%
P/E	17.8x	16.7x	20.8x	20.4x	12.9x	12.2x	10.3x	8.84x
PBR	1.62x	1.5x	1.52x	1.51x	1.41x	1.2x	1.14x	1.07x
PEG	-	2.07x	-1.1x	3.14x	0.3x	-2.75x	0.6x	0.5x
Capitalization / Revenue	2.94x	2.62x	2.61x	2.85x	2.31x	1.88x	1.76x	1.68x
EV / Revenue	3.21x	2.77x	2.79x	3.06x	2.56x	2.12x	1.91x	1.76x
EV / EBITDA	9.95x	8.14x	8.44x	9.76x	8.22x	6.81x	6.17x	5.48x
EV / EBIT	11.3x	9.13x	9.5x	11.1x	9.19x	7.6x	6.94x	6.15x
EV / FCF	15x	14x	14.2x	21.1x	13.8x	12.1x	10.7x	9.25x
FCF Yield	6.68%	7.12%	7.04%	4.74%	7.24%	8.3%	9.33%	10.8%
Dividend per Share ²	3.33	3.56	3.76	3.92	4.12	4.238	4.499	4.797
Rate of return	3.76%	3.96%	4.19%	4.18%	4.98%	5.7%	6.05%	6.45%
EPS ²	4.97	5.37	4.31	4.59	6.4	6.116	7.249	8.418
Distribution rate	67%	66.3%	87.2%	85.4%	64.4%	69.3%	62.1%	57%
Net sales ¹	37,761	42,997	43,070	41,081	43,626	47,502	50,625	53,071
EBITDA ¹	12,183	14,627	14,259	12,889	13,583	14,757	15,701	17,039
EBIT ¹	10,714	13,040	12,670	11,343	12,149	13,220	13,944	15,186
Net income ¹	6,223	6,720	5,400	5,744	7,813	7,692	9,353	10,495
Net Debt ¹	9,983	6,437	7,793	8,772	11,008	11,367	7,676	4,209
Reference price ²	88.58	89.84	89.76	93.74	82.72	74.39	74.39	74.39
Nbr of stocks (in thousands)	1,255,293	1,254,060	1,253,891	1,247,793	1,216,810	1,198,069	-	-
Announcement Date	2/4/22	2/3/23	2/1/24	1/30/25	1/29/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	34.19x	11.9x	25x	0.6%	1T
JOHNSON & JOHNSON	27.59x	6.24x	17.41x	2.11%	613B
ABBVIE INC.	33.42x	7.23x	14.91x	2.82%	433B
ROCHE HOLDING AG	19.84x	4.71x	11.66x	2.81%	350B
NOVARTIS AG	21.78x	5.64x	14.07x	2.85%	292B
ASTRAZENECA PLC	19.76x	4.1x	11.62x	2.15%	239B
NOVO NORDISK A/S	13.29x	4.98x	10.27x	3.76%	206B
AMGEN INC.	24.88x	6.52x	11.5x	2.66%	204B
GILEAD SCIENCES, INC.	-47.26x	5.67x	31.29x	2.51%	163B
Average	16.39x	6.33x	16.42x	2.48%	388.94B
Weighted average by Cap.	23.92x	7.55x	17.90x	2.05%